Strassl, I.; Schreder, M.; Steiner, N.; Rudzki, J.; Agis, H.; Künz, T.; Müser, N.; Willenbacher, W.; Petzer, A.; Neumeister, P.;
et al. The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond. Cancers 2021, 13, 4701.
https://doi.org/10.3390/cancers13184701
AMA Style
Strassl I, Schreder M, Steiner N, Rudzki J, Agis H, Künz T, Müser N, Willenbacher W, Petzer A, Neumeister P,
et al. The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond. Cancers. 2021; 13(18):4701.
https://doi.org/10.3390/cancers13184701
Chicago/Turabian Style
Strassl, Irene, Martin Schreder, Normann Steiner, Jakob Rudzki, Hermine Agis, Tina Künz, Nino Müser, Wolfgang Willenbacher, Andreas Petzer, Peter Neumeister,
and et al. 2021. "The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond" Cancers 13, no. 18: 4701.
https://doi.org/10.3390/cancers13184701
APA Style
Strassl, I., Schreder, M., Steiner, N., Rudzki, J., Agis, H., Künz, T., Müser, N., Willenbacher, W., Petzer, A., Neumeister, P., & Krauth, M. T.
(2021). The Agony of Choice—Where to Place the Wave of BCMA-Targeted Therapies in the Multiple Myeloma Treatment Puzzle in 2022 and Beyond. Cancers, 13(18), 4701.
https://doi.org/10.3390/cancers13184701